Status:
UNKNOWN
Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery
Lead Sponsor:
Assiut University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Our aim will be to evaluate the efficacy of perioperative Duloxetine in decreasing acute postoperative pain after laparoscopic colorectal cancer surgery and its role in reducing postoperative morphine...
Detailed Description
Abdominal surgery is usually associated with severe; wide spread post-operative pain. The greater propensity for pain and opioid-related side effects are likely contributing factors for poor postsurgi...
Eligibility Criteria
Inclusion
- ASA I-III
- aged 18-65 years and scheduled for laparoscopic colorectal surgery for cancer colon
Exclusion
- unable to express their pain or patient refusal.
- allergy to the study drug
- an abnormal liver or renal function tests
- a chronic opioid abuser(\> 3 mo), being on chronic gabapentin or pregabalin(\> 3 mo)
- antidepressant drugs, patients with psychiatric disorders
- Pregnant females
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04294953
Start Date
March 1 2020
End Date
April 1 2021
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.